Tag: Eisai Co Ltd
Schizophrenia drug Cobenfy could treat Alzheimer’s
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glan [...]
Biogen (BIIB) earnings Q3 2024
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021.Dado Ruvic | ReutersBiogen on Wednesday reported [...]
Leqembi could give Alzheimer’s patients more time, but road to treatment is long
Hannah Yoon | The Washington Post | Getty ImagesLeqembi, an Alzheimer's drug from Biogen and Eisai, isn't a cure for the mind-damaging disease. But t [...]
Eisai Biogen Alzheimer’s drug Leqembi shows benefits over three years
The newly FDA approved Alzheimer's treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023. H [...]
Novo Nordisk GLP-1 liraglutide may slow Alzheimer’s progression
A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, January 9, 2020.George Frey | ReutersA [...]
Biogen (BIIB) earnings Q1 2024
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021.Dado Ruvic | ReutersBiogen on Wednesday reported [...]
Eli Lilly Alzheimer’s drug FDA approval delayed
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.'s shares climbed in early US trading after its exp [...]
Biogen (BIIB) earnings Q4 2023
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen on Tuesday reported fourth-quarter revenue and profit that shrank from a ye [...]
Biogen drops Alzheimer’s drug Aduhelm to focus on Leqembi, others
The Biogen headquarters in Cambridge, Massachusetts, on Tuesday, Oct. 24, 2023.Vanessa Leroy | Bloomberg | Getty ImagesBiogen on Wednesday said it wil [...]
Pharma had a year full of firsts
Soumyabrata Roy | Nurphoto | Getty ImagesDrugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutic [...]
Pfizer weight loss pill joins list of obesity drug flops
Sopa Images | Lightrocket | Getty ImagesPfizer's twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped [...]
Alzheimer’s drug Leqembi shows promise as injection
Eisai on Wednesday said an injectable version of the Alzheimer's drug Leqembi showed promising initial results in a clinical trial, potentially paving [...]
Eli Lilly expects FDA decision on donanemab by year-end
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesEli Lilly on Monday said [...]
What patients and doctors should know
The Alzheimer's drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023.Eisai | via ReutersMedicare has agreed to p [...]
Alzheimer’s drug Leqembi sales may be slow at first: Analysts
Jay Reinstein, who suffers from Alzheimer's, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, [...]